Dublin, December 30, 2024 (GLOBE NEWSWIRE) — The “Direct-to-consumer genetic testing market and technologies” the report has been added to ResearchAndMarkets.com offer.
The direct-to-consumer genetic testing market was valued at $2.3 billion in 2024 and is expected to reach $3.7 billion by 2029, growing at a CAGR of 10%. For each segment, current products are identified for the base year 2023, current market size is measured and market drivers identified, forecasts are made for 2029 and current market shares of companies are assessed.
The report analyzes the DTC genetic testing market, providing an overview of the competitive landscape along with revenues, product portfolios and recent developments of leading companies. The report analyzes market trends and dynamics, including drivers, limitations, challenges, and opportunities. It assesses current and potential market size, to help industry executives make informed decisions regarding the production and licensing of goods and services. The study segments the market based on segment/application type, such as ancestry, health, and lifestyle.
Regional market analysis is provided for all major segments. The report covers direct-consumer-ordered tests and consumer-initiated, physician-monitored tests. DTC genetic testing on animals is outside the scope of the report. Regional market analysis is provided for all major segments, and this includes country-level analysis.
This report reviews major DTC genetic testing technologies, including next-generation sequencing (NGS) and genotyping microarrays.
The report includes:
- 18 data tables and 27 additional tables
- An overview of the global market and technologies for direct-to-consumer genetic testing
- Analyzes of global market trends, with data from 2021 to 2023, estimates for 2024, and projections of compound annual growth rates (CAGR) to 2029.
- Assessment of current market size and revenue growth prospects, accompanied by market share analysis by product type and region
- Forecasts of future trends, including regulatory challenges, patent review, ESG trends and emerging technologies
- Market share analysis of key industry companies and coverage of mergers and acquisitions, joint ventures, collaborations, partnerships and other strategies
- Profiles of key players including: Ancestry, 23andMe, MyHeritage, myDNA, Dante Labs and Color Health
Key attributes:
| Report attribute | Details |
| Number of pages | 84 |
| Forecast period | 2024 – 2029 |
| Estimated market value (USD) in 2024 | $2.3 billion |
| Projected Market Value (USD) by 2029 | $3.7 billion |
| Compound annual growth rate | 10.0% |
| Regions covered | Global |
Key topics covered:
Chapter 1 Summary
- Market Outlook
- Scope of the report
- Market Summary
Chapter 2 Market Overview
- Market Overview and Definitions
- Genetic testing
- History of DTC Genetic Testing
- Types of DTC Genetic Tests
- Regulatory framework
- UNITED STATES
- Europe
- Asia-Pacific
Chapter 3 Market Dynamics
- Market dynamics
- Market factors
- Lower cost of genomic sequencing
- Aggressive marketing
- Pharmacogenomic testing
- Increasing prevalence of chronic diseases
- Increase awareness
- Market Opportunities
- Improve patient-doctor collaboration
- Market restrictions
- Inefficiencies of DTC genetic testing
- Limited insurance coverage
- Privacy issues
- False results
- Costs of increasing referrals
- Market Challenges
- Supply Chain Challenges
- Data management, quality control and customer service
Chapter 4 Emerging Technologies and Developments
- Preview
- Artificial intelligence
- WGS and WES
- Blockchain Technology
- Genomic data in drug development
Chapter 5 DTC Genetic Testing Market
- Distribution of segmentations
- Market breakdown, by product type
- Ancestry DTC Genetic Testing Market
- Health DTC Genetic Testing Market
- Lifestyle DTC Genetic Testing Market
- Geographic distribution
- Market breakdown, by region
- North America
- Europe
- Asia-Pacific
- Latin America
- Rest of the world
Chapter 6 Competitive Intelligence
- Industry scenario
- Company shares
- Competitive landscape
Chapter 7 Sustainability in the DTC Genetic Testing Industry: An ESG Perspective
- Introduction to ESG
- Environmental performance
- Social performance
- Governance performance
- Concluding Remarks
Chapter 8 Patent Analysis
Chapter 9 Appendix
Featured Companies
- 23andMe Inc.
- Ancestry
- Couleur Santé Inc.
- Dante Labs Worldwide
- Mydna Life Australia Pty Ltd.
- MyHeritage Ltd.
- Diagnosis Privapath
For more information on this report, visit https://www.researchandmarkets.com/r/b6lzaj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of market research reports and international market data. We provide you with the latest data on international and regional markets, key industries, largest companies, new products and latest trends.